文献速递咽喉与嗓音

富血小板血浆声带上皮下输注治疗声带瘢痕、沟槽和萎缩的安全性

Safety of Platelet-Rich Plasma Subepithelial Infusion for Vocal Fold Scar, Sulcus, and Atrophy.
PubMed 文献 · Laryngoscope · 2022-07-13

前瞻性临床试验初步报告,12例声带瘢痕或萎缩患者接受单侧声带上皮下自体富血小板血浆注射,共43次注射,间隔1个月,平均注射量1.57±0.4 cc,随访3.6±1.8个月,无显著炎症反应或不良事件,3个月随访时VHI-10和VFI均显著改善(n=9)。

要点

  • 富血小板血浆声带上皮下输注耐受良好,无围手术期并发症。
  • 3个月随访时VHI-10平均改善10.8分(p<0.001),VFI平均改善18.9分(p=0.01)。
  • 完成四次注射的9例患者均主观满意,但主观改善需进一步研究临床验证。

核心结论

  • 本前瞻性研究队列显示富血小板血浆声带上皮下输注安全性良好,无不良事件或围手术期并发症,主观音质改善和声带疲劳减轻需进一步研究临床验证。

研究设计与样本

  • 前瞻性临床试验的初步报告,纳入声带瘢痕或萎缩患者,接受单侧声带上皮下自体富血小板血浆输注,共四次注射,间隔1个月。
  • 12例患者共完成43次注射,采用经口或经皮途径,平均注射量1.57±0.4 cc(范围0.6-2.0 cc),平均随访3.6±1.8个月。

主要发现

  • 所有患者均耐受操作,无困难或围手术期并发症,至今未见显著炎症反应或不良事件。
  • 3个月随访时(n=9)患者报告结局显著改善:VHI-10平均变化10.8分(p<0.001),VFI平均变化18.9分(p=0.01),采用配对双样本双尾t检验。
  • 完成四次注射系列的9例患者均主观(是/否)报告对结果满意。

局限性

  • 主观音质改善和声带疲劳减轻需进一步研究临床验证。
  • 证据等级为4级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To demonstrate the safety profile of platelet-rich plasma (PRP) as an injectable therapeutic for the treatment of vocal fold scarring and atrophy. METHODS: Preliminary report on a prospective clinical trial of patients with vocal fold scar or atrophy undergoing unilateral vocal fold subepithelial infusion with autologous PRP. Enrolled patients underwent four subepithelial injections spaced 1 month apart. Adverse events were assessed peri and post-injection at each session. Patient-reported outcomes were collected at every visit using the Voice Handicap Index-10 (VHI-10) and Vocal Fatigue Index (VFI) questionnaires. RESULTS: Twelve patients underwent unilateral vocal fold injection with autologous PRP prepared according to Eclipse PRP® system protocol. Forty-three injections were performed using a peroral or percutaneous approach. An average of 1.57 ± 0.4 cc (range 0.6-2.0 cc) injectate was used. All patients tolerated the procedure without difficulty or peri-procedural complications. The average duration of follow-up was 3.6 ± 1.8 months. No significant inflammatory reactions or adverse events were seen to date. There was statistically significant improvement in patient-reported outcomes at the 3 month follow up (n = 9) follow-up (mean ΔVHI-10 = 10.8, p < 0.001, mean ΔVFI = 18.9, p = 0.01, t test, paired two sample for means, two-tail). All nine patients who completed the series of four injections subjectively (yes/no) reported they were satisfied with the results. CONCLUSION: This prospective study cohort demonstrated a favorable safety profile, with no adverse events or peri-procedural complications. Subjective improvements in vocal quality and reduction in vocal fatigue need to be clinically correlated with further study. LEVEL OF EVIDENCE: 4 Laryngoscope, 133:647-653, 2023.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. van der Woerd B, O'Dell K, Castellanos CX, et al. Safety of Platelet-Rich Plasma Subepithelial Infusion for Vocal Fold Scar, Sulcus, and Atrophy. Laryngoscope. 2022. PMID: 35822344. doi:10.1002/lary.30288

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。